Abstract| Volume 241, ISSUE 1, e28, July 2015

HDL cholesterol efflux capacity and cardiovascular mortality

      Background: A causal role of HDL in the development of atherosclerosis is still under debate. A more important factor may be represented by HDL cholesterol efflux capacity, the first and most likely rate-limiting step of the reverse cholesterol transport. Recent studies regarding the association between HDL cholesterol efflux capacity and incident cardiovascular events, however, yielded conflicting data. In this report, we present a prospective observational study of patients referred to coronary angiography in which cholesterol efflux was examined in relation to morbidity and mortality.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect